An Asp to Strike Out Cancer? Therapeutic Possibilities Arising from Aspartate's Emerging Roles in Cell Proliferation and Survival.

An Asp to Strike Out Cancer? Therapeutic Possibilities Arising from Aspartate's Emerging Roles in Cell Proliferation and Survival.
复制标题

DOI:
10.3390/biom11111666
复制
发表时间:
2021-11-10
期刊:
影响因子:
5.5
通讯作者:
Yeh JJ
Yeh JJ
中科院分区:
生物学2区
文献类型:
--
作者:
Helenius IT;Madala HR;Yeh JJ

文献摘要

参考文献

被引文献

相似文献

更好地理解肿瘤的代谢限制可能会带来更有效的抗癌治疗方法。近年来有证据表明,许多肿瘤类型对天冬氨酸存在关键的依赖性。作为核苷酸合成的前体,天冬氨酸对细胞增殖必不可少。此外,苹果酸 - 天冬氨酸穿梭在氧化还原平衡中起着关键作用,天冬氨酸缺乏会导致氧化应激。现在人们认识到,天冬氨酸的生物合成在很大程度上受线粒体代谢的调控,包括癌细胞中的呼吸作用和谷氨酰胺分解。因此,在抑制线粒体代谢的条件下,包括突变、缺氧或化学抑制剂的作用下,天冬氨酸会成为肿瘤生长和癌细胞存活的限制因素。值得注意的是,天冬氨酸的可利用性与目前临床上或临床试验中的各种治疗方法的敏感性或耐药性有关,这表明迫切需要更有效的针对天冬氨酸的方法。在这篇综述中,我们介绍了目前关于天冬氨酸在癌细胞中代谢作用的知识,并描述了癌细胞在不同代谢状态下如何维持天冬氨酸水平。我们还重点介绍了几种目前正在研究的、有前景的天冬氨酸水平调节剂。
A better understanding of the metabolic constraints of a tumor may lead to more effective anticancer treatments. Evidence has emerged in recent years shedding light on a crucial aspartate dependency of many tumor types. As a precursor for nucleotide synthesis, aspartate is indispensable for cell proliferation. Moreover, the malate–aspartate shuttle plays a key role in redox balance, and a deficit in aspartate can lead to oxidative stress. It is now recognized that aspartate biosynthesis is largely governed by mitochondrial metabolism, including respiration and glutaminolysis in cancer cells. Therefore, under conditions that suppress mitochondrial metabolism, including mutations, hypoxia, or chemical inhibitors, aspartate can become a limiting factor for tumor growth and cancer cell survival. Notably, aspartate availability has been associated with sensitivity or resistance to various therapeutics that are presently in the clinic or in clinical trials, arguing for a critical need for more effective aspartate-targeting approaches. In this review, we present current knowledge of the metabolic roles of aspartate in cancer cells and describe how cancer cells maintain aspartate levels under different metabolic states. We also highlight several promising aspartate level-modulating agents that are currently under investigation.
癌细胞对葡萄糖限制和双胍类药物敏感性的代谢决定因素。
DOI: 10.1038/nature13110
发表时间: 2014-04-03
期刊: NATURE
影响因子: 64.8
作者:
Birsoy, Kivanc;Possemato, Richard;Lorbeer, Franziska K.;Bayraktar, Erol C.;Thiru, Prathapan;Yucel, Burcu;Wang, Tim;Chen, Walter W.;Clish, Clary B.;Sabatini, David M.
通讯作者: Sabatini, David M.
DOI: 10.1016/j.celrep.2019.06.010
发表时间: 2019-07-02
期刊: CELL REPORTS
影响因子: 8.8
作者:
Bacci, Marina;Lorito, Nicla;Morandi, Andrea
通讯作者: Morandi, Andrea
DOI: 10.1172/jci81568
发表时间: 2016-10-01
影响因子: 15.9
作者:
Jones, Robert A.;Robinson, Tyler J.;Zacksenhaus, Eldad
通讯作者: Zacksenhaus, Eldad
DOI: 10.1016/j.celrep.2016.09.052
发表时间: 2016-10-11
期刊: CELL REPORTS
影响因子: 8.8
作者:
Allen, Eric L.;Ulanet, Danielle B.;Smolen, Gromoslaw A.
通讯作者: Smolen, Gromoslaw A.
DOI: 10.1073/pnas.1617922114
发表时间: 2017-04-25
影响因子: 11.1
作者:
Ilic, Nina;Birsoy, Kivanc;Hahn, William C.
通讯作者: Hahn, William C.